Morten Lundh is the Director of Drug Discovery Innovation at Gubra. In 2013, he obtained his PhD degree from University of Copenhagen (included training at the Broad Institute, Boston), followed by a post-doc (University of Copenhagen). In 2018 Morten moved to Gubra working as a scientist, but gradually transitioned into a project leader, in which he led several internal projects for more than 3 years. Morten is currently responsible for identifying and qualifying novel peptide drug discovery ideas. Morten has contributed significantly to the development of the streaMLine platform, and he continues to push the platform towards new challenges.